It appears you're using an older browser. BioHiTech.com will work better for you if you upgrade your browser or switch to another browser.
BioHiTech Global, Inc. Approved for Nasdaq Listing

CHESTNUT RIDGE, N.Y., April 6, 2018 /PRNewswire/ -- BioHiTech Global, Inc. ("BioHiTech" or the "Company") (OTCQB: BHTG), a technology and services company that provides cost-effective and sustainable waste management solutions, today announced that The NASDAQ Stock Market LLC has approved the Company's application to list its common stock on The Nasdaq Capital Market®.

BioHiTech Global, Inc. (PRNewsfoto/BioHiTech Global, Inc.)

It is anticipated that BioHiTech's common stock will commence trading on The Nasdaq Capital Market on April 9, 2018, using its current ticker symbol, BHTG.

"We are pleased to have achieved this important milestone for BioHiTech as we continue our efforts to build lasting value for our stockholders," stated Frank E. Celli, CEO of BioHiTech. "The Nasdaq listing will provide our Company with greater corporate visibility and improved liquidity for our common stock through broader exposure to the investment community. We are confident that this will give BioHiTech a greater ability to capitalize on the significant market opportunity for our sustainable technology solutions in the waste management industry."

About BioHiTech Global
BioHiTech Global, Inc. (OTCQB: BHTG), is changing the way we think about managing waste. Our innovative waste management services combined with our disruptive technologies provide sustainable waste disposal and supply chain management solutions for businesses and municipalities of all sizes. Our technology platform, including the on and off-site biological treatment of waste, is designed to reduce overall waste generation and virtually eliminate landfill usage while creating a valuable renewable fuel.  For more information, please visit www.biohitech.com.

Forward Looking Statements
Statements in this document contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are based on many assumptions and estimates and are not guarantees of future performance. These statements may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of BioHiTech Global, Inc. to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. BioHiTech Global, Inc. assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Our actual results may differ materially from the results anticipated in these forward-looking statements due to a variety of factors, including, without limitation those set forth as "Risk Factors" in our filings with the Securities and Exchange Commission ("SEC"). There may be other factors not mentioned above or included in the BioHiTech's SEC filings that may cause actual results to differ materially from those projected in any forward-looking statement. BioHiTech Global, Inc. assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by securities laws.

Company Contact:
BioHiTech Global, Inc.
Richard Galterio
Executive Vice President
Direct: 845.367.0603
rgalterio@biohitech.com
www.biohitech.com

SOURCE BioHiTech Global, Inc.


print email rss
Price Data
NASDAQBHTG
NASDAQBHTG